Don Healey
Senior VP, Operations,
Department of Pathology
KBI Biopharma
United States of America
Biography
Don has over 30 years experience in cellular immunology and immune regulation in both academic and biotech environments. Prior to joining KBI Biopharma, Don was Chief Scientific Officer at Opexa Therapeutics, developing autologous T-cell immunotherapies for the treatment of autoimmune disease. Previously, he held the position of Director of Immunology at Argos Therapeutics.
Research Interest
Pathology
